294 related articles for article (PubMed ID: 16701601)
1. Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms.
Aquilante CL; Langaee TY; Anderson PL; Zineh I; Fletcher CV
Clin Chim Acta; 2006 Oct; 372(1-2):195-8. PubMed ID: 16701601
[TBL] [Abstract][Full Text] [Related]
2. Genotyping cytochrome P450 3A5 using the Light Cycler.
Fredericks S; Moreton M; MacPhee IA; Mohamed M; Marlowe S; Jorga A; Johnston A; Carter ND; Holt DW
Ann Clin Biochem; 2005 Sep; 42(Pt 5):376-81. PubMed ID: 16168193
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
Aquilante CL; Lobmeyer MT; Langaee TY; Johnson JA
Pharmacotherapy; 2004 Jun; 24(6):720-6. PubMed ID: 15222661
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism analysis of CYP3A5 in myeloid leukemia.
Liu TC; Lin SF; Chen TP; Chang JG
Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus.
Zhao Y; Song M; Guan D; Bi S; Meng J; Li Q; Wang W
Transplant Proc; 2005; 37(1):178-81. PubMed ID: 15808586
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients.
Larriba J; Imperiali N; Groppa R; Giordani C; Algranatti S; Redal MA
Transplant Proc; 2010; 42(1):257-9. PubMed ID: 20172323
[TBL] [Abstract][Full Text] [Related]
7. Genotyping and detection of multiple infections of Toxoplasma gondii using Pyrosequencing.
Sreekumar C; Hill DE; Miska KB; Vianna MC; Yan L; Myers RL; Dubey JP
Int J Parasitol; 2005 Aug; 35(9):991-9. PubMed ID: 15990100
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
9. HLA class II DRB high resolution genotyping by pyrosequencing: comparison of group specific PCR and pyrosequencing primers.
Ringquist S; Alexander AM; Styche A; Pecoraro C; Rudert WA; Trucco M
Hum Immunol; 2004 Feb; 65(2):163-74. PubMed ID: 14969771
[TBL] [Abstract][Full Text] [Related]
10. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes.
Ruan L; Pei B; Li Q
Transfusion; 2007 Sep; 47(9):1637-42. PubMed ID: 17725728
[TBL] [Abstract][Full Text] [Related]
11. Genotyping for cytochrome P450 polymorphisms.
Daly AK; King BP; Leathart JB
Methods Mol Biol; 2006; 320():193-207. PubMed ID: 16719392
[TBL] [Abstract][Full Text] [Related]
12. Multiplex single nucleotide polymorphism genotyping by adapter ligation-mediated allele-specific amplification.
Wang WP; Ni KY; Zhou GH
Anal Biochem; 2006 Aug; 355(2):240-8. PubMed ID: 16836969
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
Wei-lin W; Jing J; Shu-sen Z; Li-hua W; Ting-bo L; Song-feng Y; Sheng Y
Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701
[TBL] [Abstract][Full Text] [Related]
14. Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population.
Quaranta S; Chevalier D; Bourgarel-Rey V; Allorge D; Solas C; Lo-Guidice JM; Sampol-Manos E; Vacher-Coponat H; Moal V; Broly F; Lhermitte M; Lacarelle B
Toxicol Lett; 2006 Jul; 164(2):177-84. PubMed ID: 16442753
[TBL] [Abstract][Full Text] [Related]
15. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
[TBL] [Abstract][Full Text] [Related]
16. An extensive polymerase chain reaction-allele-specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles.
Hosseini-Maaf B; Hellberg A; Chester MA; Olsson ML
Transfusion; 2007 Nov; 47(11):2110-25. PubMed ID: 17958541
[TBL] [Abstract][Full Text] [Related]
17. TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia.
Kang HJ; Oh Y; Chun SM; Seo YJ; Shin HY; Kim CW; Ahn HS; Han BD
Mol Cell Probes; 2008 Jun; 22(3):193-200. PubMed ID: 18385010
[TBL] [Abstract][Full Text] [Related]
18. Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations.
Lee SS; Kim WY; Jang YJ; Shin JG
Clin Chim Acta; 2008 Dec; 398(1-2):82-5. PubMed ID: 18775689
[TBL] [Abstract][Full Text] [Related]
19. [A new genotyping method, PCR-CTPP].
Atsuta Y; Hamajima N
Rinsho Byori; 2003 Sep; 51(9):886-91. PubMed ID: 14560658
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
